CALR and myeloproliferative neoplasm: 2: Aberrant binding of mutant calreticulin dimers to the thrombopoietin receptor MPL mediates receptor dimerization and leads to constitutive activation of JAK‐STAT signaling, promoting proliferation of MPN cells.